Unknown

Dataset Information

0

Combination of consensus and ensemble docking strategies for the discovery of human dihydroorotate dehydrogenase inhibitors.

ABSTRACT: The inconsistencies in the performance of the virtual screening (VS) process, depending on the used software and structural conformation of the protein, is a challenging issue in the drug design and discovery field. Varying performance, especially in terms of early recognition of the potential hit compounds, negatively affects the whole process and leads to unnecessary waste of the time and resources. Appropriate application of the ensemble docking and consensus-scoring approaches can significantly increase reliability of the VS results. Dihydroorotate dehydrogenase (DHODH) is a key enzyme in the pyrimidine biosynthesis pathway. It is considered as a valuable therapeutic target in cancer, autoimmune and viral diseases. Based on the conducted benchmark study and analysis of the effect of different combinations of the applied methods and approaches, here we suggested a structure-based virtual screening (SBVS) workflow that can be used to increase the reliability of VS.

SUBMITTER: Chilingaryan G 

PROVIDER: S-EPMC8169699 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Combination of consensus and ensemble docking strategies for the discovery of human dihydroorotate dehydrogenase inhibitors.

Chilingaryan Garri G   Abelyan Narek N   Sargsyan Arsen A   Nazaryan Karen K   Serobian Andre A   Zakaryan Hovakim H  

Scientific reports 20210601 1

The inconsistencies in the performance of the virtual screening (VS) process, depending on the used software and structural conformation of the protein, is a challenging issue in the drug design and discovery field. Varying performance, especially in terms of early recognition of the potential hit compounds, negatively affects the whole process and leads to unnecessary waste of the time and resources. Appropriate application of the ensemble docking and consensus-scoring approaches can significan  ...[more]

Similar Datasets

Unknown Molecular docking analysis of Plasmodium falciparum dihydroorotate dehydrogenase towards the design of effective inhibitors.
| S-EPMC8457017 | biostudies-literature
Unknown Discovery of potential natural dihydroorotate dehydrogenase inhibitors and their synergism with brequinar via integrated molecular docking, dynamic simulations and in vitro approach.
| S-EPMC9646789 | biostudies-literature
Unknown Structure-Based Discovery and Development of Highly Potent Dihydroorotate Dehydrogenase Inhibitors for Malaria Chemoprevention.
| S-EPMC11726676 | biostudies-literature
Unknown 3D-QSAR studies of triazolopyrimidine derivatives of Plasmodium falciparum dihydroorotate dehydrogenase inhibitors using a combination of molecular dynamics, docking, and genetic algorithm-based methods.
| S-EPMC3375378 | biostudies-literature
Unknown Dihydroorotate dehydrogenase inhibitors in SARS-CoV-2 infection.
| S-EPMC7435507 | biostudies-literature
Unknown Identification of Dihydroorotate Dehydrogenase Inhibitors Using the Cell Painting Assay.
| S-EPMC9828254 | biostudies-literature
Unknown Original 2-(3-Alkoxy-1H-pyrazol-1-yl)azines Inhibitors of Human Dihydroorotate Dehydrogenase (DHODH).
| S-EPMC4516315 | biostudies-literature
Unknown Exponential consensus ranking improves the outcome in docking and receptor ensemble docking.
| S-EPMC6435795 | biostudies-literature
Unknown Selective Cytotoxicity of Dihydroorotate Dehydrogenase Inhibitors to Human Cancer Cells Under Hypoxia and Nutrient-Deprived Conditions.
| S-EPMC6131557 | biostudies-literature
Unknown The Dihydroorotate Dehydrogenase Inhibitor Brequinar Is Synergistic with ENT1/2 Inhibitors.
| S-EPMC7737209 | biostudies-literature